Teladoc Health (TDOC) Gross Profit (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Gross Profit data on file, last reported at $416.3 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 28.3% year-over-year to $416.3 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (up 21.71% YoY), and the FY2025 full-year result was $2.3 billion, up 28.44% from the prior year.
• Gross Profit fell to $416.3 million in Q1 2026, from $594.6 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.0 billion in Q4 2023 to a low of $41.5 million in Q4 2024.
• A 5-year average of $505.2 million and a median of $474.3 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit slumped 95.91% in 2024 and soared 1333.2% in 2025, its largest moves.
• Tracing TDOC's Gross Profit over 5 years: stood at $448.8 million in 2022, then soared by 125.77% to $1.0 billion in 2023, then tumbled by 95.91% to $41.5 million in 2024, then soared by 1333.2% to $594.6 million in 2025, then declined by 29.98% to $416.3 million in 2026.
• Business Quant data shows TDOC's Gross Profit at $416.3 million in Q1 2026, $594.6 million in Q4 2025, and $439.3 million in Q3 2025.